Actively Recruiting

Age: 25Years - 85Years
FEMALE
ID06655506

Enhanced Recovery Protocols in Gynecological Cancer Patients: a Feasibility Study

Led by National and Kapodistrian University of Athens · Updated on 2024-10-23

600

Participants Needed

8

Research Sites

17 weeks

Total Duration

On this page

Sponsors

N

National and Kapodistrian University of Athens

Lead Sponsor

U

University of Thessaly

Collaborating Sponsor

AI-Summary

What this Trial Is About

Enhanced Recovery After Surgery (ERAS) protocols are designed to provide a structured approach for managing patients after surgery, promoting evidence-based care to support normal body function during the perioperative period and help patients recover sooner. This study focuses on women with gynecological cancer in Greece, aiming to assess how well ERAS protocols can be followed and their feasibility in clinical practice. It also compares outcomes between patients who meet a minimum compliance level with ERAS criteria and those who do not. Participants will be grouped based on their compliance with the ERAS protocols: one group includes patients who exceed 80% compliance with predetermined ERAS criteria, while the other group includes patients who do not meet this threshold. The ERAS protocols involve steps such as pre-admission education, nutritional care before surgery, specific medication plans, standardized anesthesia, fluid management during surgery, multimodal pain relief, early movement, and early removal of urinary catheters. During the study, patients will be registered before surgery and monitored for various outcomes, including length of hospital stay and perioperative infections within 30 days after surgery. Other assessments include postoperative quality of life, complications using a classification system, time until additional therapy, and long-term outcomes like recurrence rates and overall survival over three years. A quality assurance program will support both groups to ensure proper data collection and care standards.

CONDITIONS

Brief Title

Enhanced Recovery Protocols in Gynecologic Oncology

Who Can Participate

Age: 25Years - 85Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients aged 25 to 85 years
  • Diagnosed with gynecological cancer
  • ECOG performance status less than 4
  • ASA score less than 4
Not Eligible

You will not qualify if you...

  • Patients with metastatic cancer of non-gynecological origin
  • Patients unable to follow ERAS protocol due to medical reasons
  • Patients with severe debilitating comorbidities (ECOG status 4, ASA score 4-5)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surgery and Immediate Post-operative Care

Duration - Up to 30 days postoperatively

Participants undergo surgery and receive immediate post-operative care as part of the Enhanced Recovery protocols.

Approximately 1 hospital stay and post-operative assessments

Post-operative Follow-up

Duration - Up to 3 years

Participants are monitored after surgery to assess recovery, postoperative quality of life, morbidity, interval to adjuvant therapy, and longer-term outcomes.

Follow-up visits up to 3 years including assessments at 30 days, 100 days, and annually for recurrence and survival

Trial Site Locations

Total: 8 locations

1

First department of Obstetrics and Gynecology

Athens, Athens, Greece, 11523

Actively Recruiting

2

Agios Savvas Anticancer Hospital

Athens, Attica, Greece, 11522

Actively Recruiting

3

First department of Obstetrics and Gynecology, National and Kapodistrian University of Athens

Athens, Attica, Greece, 11528

Actively Recruiting

4

University of Thessaly

Larissa, Larissa, Greece, 413 34

Actively Recruiting

5

Metaxa Anticancer Hospital

Athens, Piraeus, Greece, 18537

Not Yet Recruiting

6

Aristotle University of Thessaloniki, Second department of Obstetrics and Gynecology

Thessaloniki, Thessaloniki, Greece, 54642

Actively Recruiting

7

Aristotle University of Thessaloniki, Third department of Obstetrics and Gynecology

Thessaloniki, Thessaloniki, Greece, 54642

Actively Recruiting

8

Aristotle University of Thesalloniki, Papageorgiou Hospiral

Thessaloniki, Thessaloniki, Greece, 56429

Actively Recruiting

Loading map...

Research Team

N

Nikolaos Thomakos, MD, PhD

V

Vasilios Pergialiotis, MD, PhD, MSc

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Study of 3D-printed Custom Applicators for Intracavitary HDR...

Gynecologic Cancer

Actively Recruiting

1 location

A Multi-Modality Comparison of Needle Placement During Gynec...

Gynecologic Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Thoracic epidural analgesia as part of an enhanced recovery program in gynecologic oncology: a prospective cohort study.

Anastasios Pandraklakis, Dimitrios Haidopoulos, Theodoros Lappas...

https://pubmed.ncbi.nlm.nih.gov/37652530

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.

G Nelson, C Fotopoulou, J Taylor...

https://pubmed.ncbi.nlm.nih.gov/37086524

Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: an international survey of peri-operative practice.

Geetu Prakash Bhandoria, Prashant Bhandarkar, Vijay Ahuja...

https://pubmed.ncbi.nlm.nih.gov/32753562

Implementation Rates and Predictors of Compliance with Enhanced Recovery After Surgery Protocols in Gynecologic Oncology: A Prospective Multi-Institutional Cohort Study.

Vasilios Pergialiotis, Dimitrios Haidopoulos, Alexandros Daponte...

https://pubmed.ncbi.nlm.nih.gov/41463241